Development of a preventive vaccine for Ebola virus infection in primates

By N. Sullivan, A. Sanchez, P. Rollin, Zhi-yong Yang, G. Nabel. Nature, 2000

663 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/fc103c5a59555e4933c9ff5c5393a71b1928d2c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Jones
2. U. Ströher
3. J. Geisbert
4. L. Fernando
5. A. Grolla
6. H. Klenk
7. V. Volchkov
8. Elizabeth A. Fritz

Citations in the corpus

• Adenoviruses as vaccine vectors (2004, neutral): “Rabies virus Rodent, dog Glycoprotein CMI and antibody [40,68,70,71,93,94, 110–112] Dengue virus Rodent Envelope CMI and antibody [113] Ebola virus Rodent, NHP Glycoprotein, nucleoprotein CMI and antibody [83,114] SARS–coronavirus Rodent, NHP Spike, nucleocapsid, membrane protein CMI and antibody [8”
• Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses (2005, methodology): “The first EBOV vaccine to protect nonhuman primates was a DNA prime–adenovirus boost approach using both the glycoprotein and nucleoprotein as target antigen”